Axel Hyrenius-Wittsten

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Aortic Dissection

Metastatic Colorectal Cancer

Endoplasmic Reticulum Stress

Top Venues

Science translational medicine

Nature communications

University of California San Francisco

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Francisco Nov 29o 2017

United States

Postdoc :: Parker Institute for Cancer Immunotherapy

Publications

Axel Hyrenius-Wittsten, Yang Su, Minhee Park, Julie M Garcia, Josef Alavi, Nathaniel Perry, Garrett Montgomery, Bin Liu, Kole T Roybal
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models. Science translational medicine 13 (591) (2021)
Axel Hyrenius-Wittsten, Mattias Pilheden, Antoni Falqués-Costa, Mia Eriksson, Helena Sturesson, Pauline Schneider, Priscilla Wander, Cristian Garcia-Ruiz, Jian Liu, Helena Ågerstam, Anne Hultquist, Henrik Lilljebjorn, Ronald W Stam, Marcus Järås, Anna K Hagström-Andersson
FLT3N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis. Leukemia 33 (9) (2019)
Axel Hyrenius-Wittsten, Mattias Pilheden, Helena Sturesson, Jenny Hansson, Michael P Walsh, Guangchun Song, Julhash U Kazi, Jian Liu, Ramprasad Ramakrishan, Cristian Garcia-Ruiz, Stephanie Nance, Pankaj Gupta, Jinghui Zhang, Lars Rönnstrand, Anne Hultquist, James R Downing, Karin Lindkvist-Petersson, Kajsa Paulsson, Marcus Järås, Tanja A Gruber, Jing Ma, Anna K Hagström-Andersson
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia. Nature communications 9 (1) (2018)